Lv3
400 积分 2023-12-30 加入
VIF-Ig: a novel fc framework for ADCC by incorporation of VHH unit
2天前
已完结
Cell Therapies and Bispecific Engagers: Redefining Strategies Against Checkpoint Resistance
5天前
已完结
Bispecific T-cell engager therapy for gastrointestinal cancers
5天前
已完结
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of non-small-cell lung cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial
12天前
已完结
Emerging importance of HER3 in tumorigenesis and cancer therapy
12天前
已完结
Antibody–drug conjugates in lung cancer: current landscape and future perspectives
12天前
已完结
Targeted precision Strike in Extensive-Stage small cell lung Cancer: Current advances and future Perspectives for Antibody–Drug conjugates
12天前
已完结
The Therapeutic Significance of HER3 in Non-small Cell Lung Cancer (NSCLC): A Review Study
12天前
已完结
HER3 upregulation reduces DS-8201 sensitivity in HER2-positive tumor cells by ATR/CHK1/FoxO1 signaling cascade
12天前
已完结
NRG1 fusions：the potential targeted treatment in non-small cell lung cancer(NSCLC)
12天前
已关闭
皖公网安备34019202002308
